Current treatment for IBD includes corticosteroids and biologics such as monoclonal antibodies targeting Tumour Necrosis Factor (TNF), but these drugs manage the disease rather than cure it, and drug failure rates are high24, precipitating the need for new approaches to treat IBD. The gene discussed is TNF; the disease is inflammatory bowel disease.